Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Medtronic; Abbott Vascular; CorWave; Endotronix; Nuwellis; Procyrion; BiVACOR; Bioventrix; Zoll; CH Biomedical; Pumpin Heart
- Equity/Stock(s)/Options - Procyrion
- DSMB - Berlin Excor; BiVacor
Video Player is loading.